Sani-Guard-SF Waterless Foam Hand Sanitizer, Ethyl Alcohol 70%, packaged in a) 6/1000 ml pouches per case, 5068-FL1000, b) 1000 ml cartridge pouch, 6/1000 ml .8ml Option Cartridge pouches per case, 5068-OS1000, Inopak LTD

Class I - Dangerous
💊 Drugs Recalled: April 22, 2019 Inopak Other Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Batch #: 6668, 6721
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Inopak Ltd
Reason for Recall:
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Sani-Guard-SF Waterless Foam Hand Sanitizer, Ethyl Alcohol 70%, packaged in a) 6/1000 ml pouches per case, 5068-FL1000, b) 1000 ml cartridge pouch, 6/1000 ml .8ml Option Cartridge pouches per case, 5068-OS1000, Inopak LTD

Product Codes/Lot Numbers:

Batch #: 6668, 6721

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1317-2019

Related Recalls

CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.

Apr 22, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.

Apr 22, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.

Apr 22, 2019 Other Drugs Nationwide View Details →